Emerging Therapies in Respiratory Disease

11th September 2007
Wellcome Trust Conference Centre, Hinxton, Cambridge

 
Programme:
 
09.00   Registration and Coffee
09.50 Introduction - Dr A J Ratcliffe, UCB
 
Session 1. Chair: Dr Ruth Lock
10.00 Prof Clive Page, King's College
Challenges facing the development of new drugs for the treatment of airway diseases
10.50 Prof Chris O'Callaghan, University of Leicester
Drug delivery to the lungs: problems and opportunities
11.45 Dr Douglas Ferguson, AstraZeneca
Mechanisms of Drug Retention in the Lung
12.30 Lunch
 
Session 2. Chair: Dr Steve Collingwood
13.20 Dr Fredrick Van Goor, Vertex Pharmaceuticals, USA
Pharmacological rescue of mutant CFTR function for the treatment of cystic fibrosis
14.00 Dr Richard Hale, Cellzome
A potent and selective Histamine H4 receptor antagonist for the treatment of allergic rhinitis
14.50 Dr Robin Fairhurst, Novartis Institutes for Biomedical Research
The Identification of Inhaled Once-Daily Long-Acting β2-Adrenoceptor Agonists for the Treatment of Asthma and COPD
15.30 Tea
 
Session 3. Chair: Dr A J Ratcliffe, UCB
16.00 Dr Hamish Ryder, Almirall, Spain
Discovery and early development of aclidinium bromide, a new long acting muscarinic antagonist for COPD
16.40 Dr Keith Biggadike, GSK
Novel Glucocorticoids
17.30 Close
 

Back to Menu


Home / Meetings / Membership / Student Bursaries / Administration
History of the SMR / SMR Award / Archive Material / Links / Contact Us